NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
NGM
Delisted
NGM was delisted on the 4th of April, 2024.
94 hedge funds and large institutions have $50.6M invested in NGM Biopharmaceuticals, Inc. Common Stock in 2023 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
94
Holders Change
-12
Holders Change %
-11.32%
% of All Funds
1.5%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
12
Increased
30
Reduced
35
Closed
24
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$1.51M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
$294K |
| 3 |
Renaissance Technologies
New York
|
$559K |
| 4 |
EC
Euclidean Capital
New York
|
$1.06M |
| 5 |
Squarepoint
New York
|
$149K |
